Atlanta—In their continued search for new and effective treatments for cancer, scientists investigating the potential of novel targeted therapies reported results of several early trials at the recent annual meeting of the American Society of Clinical Oncology held here in June.
“The research . . . is exciting not only because it shows how far we have come in understanding the disease itself, but because it demonstrates the success in translating this knowledge into practice,” said Bruce Johnson, MD, of the Dana-Farber Cancer Institute, in Boston.
Hampton T. Novel Targeted Cancer Drugs Highlighted. JAMA. 2006;296(3):270. doi:10.1001/jama.296.3.270